Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
9.38
+0.16 (1.74%)
Jul 29, 2025, 9:44 AM CST
SHA:605199 Revenue
Hainan Huluwa Pharmaceutical Group had revenue of 336.83M CNY in the quarter ending March 31, 2025, a decrease of -28.42%. This brings the company's revenue in the last twelve months to 1.28B, down -26.38% year-over-year. In the year 2024, Hainan Huluwa Pharmaceutical Group had annual revenue of 1.41B, down -21.26%.
Revenue (ttm)
1.28B
Revenue Growth
-26.38%
P/S Ratio
2.90
Revenue / Employee
608.58K
Employees
2,103
Market Cap
3.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.41B | -381.64M | -21.26% |
Dec 31, 2023 | 1.80B | 280.14M | 18.49% |
Dec 31, 2022 | 1.52B | 161.25M | 11.91% |
Dec 31, 2021 | 1.35B | 192.09M | 16.53% |
Dec 31, 2020 | 1.16B | -144.21M | -11.04% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |